The US patent holdings of homegrown Indian biotech and pharma companies

We have analysed all United States (US) patents of all homegrown Indian pharma and pharma biotech companies granted up to, and including, 2007. Only 57 companies (and associated foundations) have US patents. They hold a total of 19 biotech and 425 pharma patents. The patents protect both processes a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current science (Bangalore) 2009-01, Vol.96 (2), p.252-259
Hauptverfasser:	Sundaramoorthy, Sriramkumar, Bindu, Y. Chandra, Mehdiratta, Ritu, Saberwal, Gayatri
Format:	Artikel
Sprache:	eng
Schlagworte:	Biotechnology Business structures Design patents Medical treatment Pharmaceutical industry Pharmaceutical preparations Research facilities Subsidiary companies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We have analysed all United States (US) patents of all homegrown Indian pharma and pharma biotech companies granted up to, and including, 2007. Only 57 companies (and associated foundations) have US patents. They hold a total of 19 biotech and 425 pharma patents. The patents protect both processes and 'products'. Pharma patents have been obtained since 1990, but biotech patents since 2001. A mere 11 patents have been cited ten or more times. This study serves as a baseline to track the evolution of the US patent landscape of the Indian biotech and pharma industries in the years to come.
ISSN:	0011-3891